Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23404115 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Reduction in the Occurrence of Center-Involved Diabetic Macular Edema
Condition: Diabetic Retinopathy
Interventions: Drug: ruboxistaurin;   Drug: placebo
2 Completed Effect of Ruboxistaurin on Clinically Significant Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Ruboxistaurin;   Drug: Placebo

Indicates status has not been verified in more than two years